Detection of Extended-Spectrum Beta-Lactamases among Enterobacteriaceae by Use of Semiautomated Microbiology Systems and Manual Detection Procedures
- 1 April 2007
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 45 (4) , 1167-1174
- https://doi.org/10.1128/jcm.01988-06
Abstract
Three commercially available microbiology identification and susceptibility testing systems were compared with regard to their ability to detect extended-spectrum β-lactamase (ESBL) production in Enterobacteriaceae , i.e., the Phoenix Automated Microbiology System (BD Diagnostic Systems, Sparks, MD), the VITEK 2 System (bioMérieux, Marcy l'Etoile, France), and the MicroScan WalkAway-96 System (Dade Behring, Inc., West Sacramento, CA), using routine testing panels. One hundred fifty putative ESBL producers were distributed blindly to three participating laboratories. Conventional phenotypic confirmatory tests such as the disk approximation method, the CLSI double-disk synergy test, and the Etest ESBL were also evaluated. Biochemical and molecular characterization of β-lactamases performed at an independent laboratory was used as the reference method. One hundred forty-seven isolates of Escherichia coli , Klebsiella pneumoniae , Klebsiella oxytoca , Enterobacter cloacae , Enterobacter aerogenes , Citrobacter freundii , Serratia marcescens , Proteus mirabilis , Proteus vulgaris , and Morganella morganii were investigated. Of these isolates, 85 were identified as ESBL producers by the reference method. The remaining isolates were identified as non-ESBL producers; they were either hyperproducers of their chromosomal AmpC, Koxy, or SHV enzymes or lacked any detectable β-lactamase activity. The system with the highest sensitivity for the detection of ESBLs was the Phoenix (99%), followed by the VITEK 2 (86%) and the MicroScan (84%); however, specificity was more variable, ranging from 52% (Phoenix) to 78% (VITEK 2). The performance of the semiautomated systems differed widely with the species investigated. The sensitivities of the conventional test methods ranged from 93 to 94%. The double-disk synergy test showed the highest specificity and positive predictive value among all test methods, i.e., 97% and 98%, respectively.Keywords
This publication has 28 references indexed in Scilit:
- Utility of the VITEK 2 Advanced Expert System for Identification of Extended-Spectrum β-Lactamase Production in Enterobacter sppJournal of Clinical Microbiology, 2006
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Evaluation of Four Commercially Available Extended-Spectrum Beta-Lactamase Phenotypic Confirmation TestsJournal of Clinical Microbiology, 2005
- Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum β-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteriaJournal of Antimicrobial Chemotherapy, 2004
- False-positive extended-spectrum -lactamase tests for Klebsiella oxytoca strains hyperproducing K1 -lactamaseJournal of Antimicrobial Chemotherapy, 2004
- Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum β-lactamases isolated in JapanDiagnostic Microbiology and Infectious Disease, 2003
- Characterization of Clinical Isolates of Enterobacteriaceae from Italy by the BD Phoenix Extended-Spectrum β-Lactamase Detection MethodJournal of Clinical Microbiology, 2003
- A plasmid-mediated CMY-2 β-lactamase from an Algerian clinical isolate of Salmonella senftenbergFEMS Microbiology Letters, 1997
- Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E testEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Impact of the ampD Gene and Its Product on -Lactamase Production in Enterobscter cloacaeClinical Infectious Diseases, 1988